Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 09/14/21
End: 04/29/25
Due: 04/29/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 ) | NCT06939036 | Ariceum Therapeutics GmbH | user2@example.com | None | 2025-06-30 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |
| A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072 | NCT05017662 | Ariceum Therapeutics GmbH | user2@example.com | None | 2021-09-14 | 2025-04-29 | 2026-04-29 | - | - | 2025-07-14 |